These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33640632)

  • 1. An insight into the structure of 5-spiro aromatic derivatives of imidazolidine-2,4-dione, a new group of very potent inhibitors of tumor multidrug resistance in T-lymphoma cells.
    Żesławska E; Kucwaj-Brysz K; Kincses A; Spengler G; Szymańska E; Czopek A; Marć MA; Kaczor A; Nitek W; Domínguez-Álvarez E; Latacz G; Kieć-Kononowicz K; Handzlik J
    Bioorg Chem; 2021 Apr; 109():104735. PubMed ID: 33640632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma.
    Ali W; Spengler G; Kincses A; Nové M; Battistelli C; Latacz G; Starek M; Dąbrowska M; Honkisz-Orzechowska E; Romanelli A; Rasile MM; Szymańska E; Jacob C; Zwergel C; Handzlik J
    Eur J Med Chem; 2020 Aug; 200():112435. PubMed ID: 32505850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of selenocompounds with promising properties to reverse cancer multidrug resistance.
    Domínguez-Álvarez E; Gajdács M; Spengler G; Palop JA; Marć MA; Kieć-Kononowicz K; Amaral L; Molnár J; Jacob C; Handzlik J; Sanmartín C
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2821-2824. PubMed ID: 27156771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-aromatic hydantoin-3-acetate derivatives as inhibitors of the tumour multidrug resistance efflux pump P-glycoprotein (ABCB1): Synthesis, crystallographic and biological studies.
    Żesławska E; Kincses A; Spengler G; Nitek W; Wyrzuc K; Kieć-Kononowicz K; Handzlik J
    Bioorg Med Chem; 2016 Jun; 24(12):2815-22. PubMed ID: 27160056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance.
    Kaczor A; Nové M; Kincses A; Spengler G; Szymańska E; Latacz G; Handzlik J
    Molecules; 2020 May; 25(9):. PubMed ID: 32403277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophoric features for a very potent 5-spirofluorenehydantoin inhibitor of cancer efflux pump ABCB1, based on X-ray analysis.
    Żesławska E; Kincses A; Spengler G; Nitek W; Tejchman W; Handzlik J
    Chem Biol Drug Des; 2019 May; 93(5):844-853. PubMed ID: 30586228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dregamine and tabernaemontanine derivatives as ABCB1 modulators on resistant cancer cells.
    Paterna A; Kincses A; Spengler G; Mulhovo S; Molnár J; Ferreira MU
    Eur J Med Chem; 2017 Mar; 128():247-257. PubMed ID: 28189906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-Aided Search for 5-Arylideneimidazolone Anticancer Agents Able To Overcome ABCB1-Based Multidrug Resistance.
    Kaczor A; Szemerédi N; Kucwaj-Brysz K; Dąbrowska M; Starek M; Latacz G; Spengler G; Handzlik J
    ChemMedChem; 2021 Aug; 16(15):2386-2401. PubMed ID: 33929088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallographic studies of piperazine derivatives of 3-methyl-5-spirofluorenehydantoin in search of structural features of P-gp inhibitors.
    Żesławska E; Szymańska E; Nitek W; Handzlik J
    Acta Crystallogr C Struct Chem; 2021 Aug; 77(Pt 8):467-478. PubMed ID: 34350844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
    Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
    Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: Preparation and antitumor activity of oximes, oxime ethers and a lactam.
    Vágvölgyi M; Martins A; Kulmány Á; Zupkó I; Gáti T; Simon A; Tóth G; Hunyadi A
    Eur J Med Chem; 2018 Jan; 144():730-739. PubMed ID: 29291440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exocyclic Sulfur and Selenoorganic Compounds Towards Their Anticancer Effects: Crystallographic and Biological Studies.
    Żesławska E; Kincses A; Unger V; Tóth V; Spengler G; Nitek W; Tejchman W
    Anticancer Res; 2018 Aug; 38(8):4577-4584. PubMed ID: 30061224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents.
    Dei S; Coronnello M; Bartolucci G; Manetti D; Romanelli MN; Udomtanakunchai C; Salerno M; Teodori E
    Eur J Med Chem; 2018 Mar; 147():7-20. PubMed ID: 29421572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of stereo- and regioisomers of amino aryl esters as multidrug resistance (MDR) reversers.
    Teodori E; Contino M; Riganti C; Bartolucci G; Braconi L; Manetti D; Romanelli MN; Trezza A; Athanasios A; Spiga O; Perrone MG; Giampietro R; Gazzano E; Salerno M; Colabufo NA; Dei S
    Eur J Med Chem; 2019 Nov; 182():111655. PubMed ID: 31494468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
    Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
    Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells.
    Spengler G; Takács D; Horváth A; Riedl Z; Hajós G; Amaral L; Molnár J
    Anticancer Res; 2014 Apr; 34(4):1737-41. PubMed ID: 24692704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Arylidenerhodanines as P-gp Modulators: An Interesting Effect of the Carboxyl Group on ABCB1 Function in Multidrug-Resistant Cancer Cells.
    Żesławska E; Tejchman W; Kincses A; Spengler G; Nitek W; Żuchowski G; Szymańska E
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seleno-vs. thioether triazine derivatives in search for new anticancer agents overcoming multidrug resistance in lymphoma.
    Ali W; Garbo S; Kincses A; Nové M; Spengler G; Di Bello E; Honkisz-Orzechowska E; Karcz T; Szymańska E; Żesławska E; Starek M; Dąbrowska M; Nitek W; Kucwaj-Brysz K; Pyka P; Fioravanti R; Jacob C; Battistelli C; Zwergel C; Handzlik J
    Eur J Med Chem; 2022 Dec; 243():114761. PubMed ID: 36179403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
    Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
    Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.